Fri. Nov 18th, 2022

With Pfizer Inc.s Covid-19 vaccine on track to be authorized as early as next month, Western governments are facing an enormous logistical challenge: getting enough people shots of new vaccines.
While previous vaccination programs have spread over years and focused on specific demographics such as children or the elderly, governments are hoping to do something they never have done before and inoculate a majority of the population in a matter of months.
Even…